Pradaxa

Clock
Special Reports

The top 10 drugs losing US exclusivity in 2022

This year’s list of top losses of exclusivity covers a hefty slate of brands worth more than $17 billion in annual sales.  
eliquis

Pfizer, BMS' Eliquis cuts site-specific bleeds over rivals

Aug 29, 2020 11:16am
eliquis

Pfizer, BMS look to early screening for Eliquis boost

Nov 16, 2019 10:45am
eliquis

New Pfizer, BMS real-world data could boost Eliquis in Europe

Sep 1, 2019 5:00am
xarelto

Xarelto scripts stagnate as discounts pile up

Apr 23, 2019 10:33am
Boston Scientific HQ

Boston Scientific expands heart implant TV campaign

Aug 15, 2018 9:20am